BRPI0915241A2 - composição de trava, método de manutenção da desobstrução de um dispositivo de acesso vascular ou dispositivo de fornecimento intravascular e kit - Google Patents

composição de trava, método de manutenção da desobstrução de um dispositivo de acesso vascular ou dispositivo de fornecimento intravascular e kit

Info

Publication number
BRPI0915241A2
BRPI0915241A2 BRPI0915241A BRPI0915241A BRPI0915241A2 BR PI0915241 A2 BRPI0915241 A2 BR PI0915241A2 BR PI0915241 A BRPI0915241 A BR PI0915241A BR PI0915241 A BRPI0915241 A BR PI0915241A BR PI0915241 A2 BRPI0915241 A2 BR PI0915241A2
Authority
BR
Brazil
Prior art keywords
kit
vascular access
intravascular delivery
delivery device
access device
Prior art date
Application number
BRPI0915241A
Other languages
English (en)
Inventor
D Cary Douglas
Original Assignee
D Cary Douglas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by D Cary Douglas filed Critical D Cary Douglas
Publication of BRPI0915241A2 publication Critical patent/BRPI0915241A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0005—Use of materials characterised by their function or physical properties
    • A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/21—Acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/42—Anti-thrombotic agents, anticoagulants, anti-platelet agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M2025/0019—Cleaning catheters or the like, e.g. for reuse of the device, for avoiding replacement

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
BRPI0915241A 2008-11-12 2009-11-12 composição de trava, método de manutenção da desobstrução de um dispositivo de acesso vascular ou dispositivo de fornecimento intravascular e kit BRPI0915241A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11381608P 2008-11-12 2008-11-12
PCT/US2009/064174 WO2010056836A1 (en) 2008-11-12 2009-11-12 Catheter locking composition

Publications (1)

Publication Number Publication Date
BRPI0915241A2 true BRPI0915241A2 (pt) 2018-02-06

Family

ID=42170320

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0915241A BRPI0915241A2 (pt) 2008-11-12 2009-11-12 composição de trava, método de manutenção da desobstrução de um dispositivo de acesso vascular ou dispositivo de fornecimento intravascular e kit

Country Status (5)

Country Link
US (1) US8864742B2 (pt)
EP (1) EP2352541A4 (pt)
BR (1) BRPI0915241A2 (pt)
CA (1) CA2741890A1 (pt)
WO (1) WO2010056836A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9498384B2 (en) 2011-12-01 2016-11-22 Leigh E. Wood Assembled intermediate comprising staple fiber nonwoven web and articles
WO2019060697A1 (en) 2017-09-22 2019-03-28 Becton, Dickinson And Company 4% TRISODIC CITRATE SOLUTION FOR USE AS A CATHETER LOCK SOLUTION

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4929242A (en) * 1986-11-26 1990-05-29 Baxter International Inc. Solution and method for maintaining patency of a catheter
US6958049B1 (en) * 1998-08-25 2005-10-25 Ash Access Technology, Inc. Method of enhancing catheter patency using a citrate salt catheter lock solution
US6685694B2 (en) 1999-07-23 2004-02-03 Vasca, Inc. Methods and kits for locking and disinfecting implanted catheters
US20050215978A1 (en) 2001-05-25 2005-09-29 Ash Stephen R Method of enhancing catheter patency using a citrate salt catheter lock solution
US7749529B2 (en) 2005-02-08 2010-07-06 Ash Access Technology, Inc. Catheter lock solution comprising citrate and a paraben

Also Published As

Publication number Publication date
US20110208159A1 (en) 2011-08-25
WO2010056836A1 (en) 2010-05-20
EP2352541A4 (en) 2014-01-08
US8864742B2 (en) 2014-10-21
CA2741890A1 (en) 2010-05-20
EP2352541A1 (en) 2011-08-10

Similar Documents

Publication Publication Date Title
BRPI0908021A2 (pt) Composto, composição farmacêutica, e, usos do composto ou da composição farmacêutica
EP2134400A4 (en) PREVENTING BLOOD EXPOSURE IN VESSEL ACCESSORIES
EP2353551A4 (en) CORONARY STUDENT WITH MEDICATION-FINISHED SLICES
BRPI0908173A2 (pt) composição para cuidado pessoal, e, método para fabricar uma composição ou uma formulação antimicrobiana para cuidado pessoal
BRPI0911004A2 (pt) Artigo antimicrobiano, líquido de tratamento e métodos de preparação dos mesmos
PT2352488T (pt) Composição de rejuvenescimento cutâneo fotoactivada e oxidativa compreendendo ácido hialurónico, glucosamina, ou alantoína
BRPI0719015A2 (pt) Vedação de sangue de dispositivo de acesso vascular e prevenção de exposição
BRPI1013705A2 (pt) compostos, composição farmacêutica, método de tratamento de doença ou condição associada com função de trap1 e usos de compostos e de composição farmacêutica
BRPI0919519A2 (pt) Composição, agente herbicida, e, usos de herbicida, e da composição
BRPI0814941A2 (pt) Composição de tratamentode semente, e, método de tratamento de semente.
BRPI0913293A2 (pt) método para inibir a formação de uma biopelícula, composição farmacêutica tópica, rinsagem cirúrgica, bandagem, composição de limpeza, e, rinsagem dental.
BRPI0908635A2 (pt) composto, composição farmacêutica e método de tratamento de câncer
BRPI0921317A2 (pt) composto, composição farmacêutica, e, método para tratar ou prevenir uma patologia relacionada com abeta em um mamífero
BRPI0906962A2 (pt) Composto, e, composição farmacêutica
BRPI0906556A2 (pt) Composto, e, composição farmacêutica
BRPI0907976A2 (pt) Composto, composição farmacêutica, uso de um composto, e, método para tratar ou prevenir doenças
BRPI0911612A2 (pt) composições e métodos para o tratamento da esclerose múltipla.
BRPI0820568A2 (pt) Composto, composição farmacêutica, uso de um composto ou uma composição farmacêutica, e, método de tratamento de um humano ou animal
BRPI0913585A2 (pt) composto, método para fabricar um composto, composição farmacêutica, uso de um composto, e, método para o tratamento ou prevenção de distúrbios
BRPI0917001A2 (pt) composto, composição farmacêutica, e, uso de um composto ou uma composição farmacêutica
BRPI0821636A2 (pt) Uso de um agente de mascaramento de sabor, composição líquida, e, uso da composição líquida
BRPI0905369A2 (pt) Composição farmacêutica, composição e kit compartimentado
BRPI0907974A2 (pt) Composto, composição farmacêutica, uso de um composto, e, método para tratar ou prevenir doenças
BRPI0809601A2 (pt) Método para fabricar composto, composição para o tratamento ou a prevenção da influenza, e, composto
BRPI0908883A2 (pt) composto, composição farmacêutica, uso de um composto, e, método para tratar ou prevenir doenças

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law
B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)